Pacer Advisors Inc. lifted its stake in shares of Aetna Inc. (NYSE:AET) by 10.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,360 shares of the company’s stock after acquiring an additional 702 shares during the quarter. Pacer Advisors Inc.’s holdings in Aetna were worth $1,170,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds also recently modified their holdings of the company. State of Tennessee Treasury Department increased its holdings in Aetna by 26.3% in the second quarter. State of Tennessee Treasury Department now owns 557,814 shares of the company’s stock worth $84,692,000 after purchasing an additional 116,280 shares in the last quarter. Banque Pictet & Cie SA bought a new stake in Aetna in the second quarter worth approximately $10,567,000. Pictet & Cie Europe SA bought a new stake in Aetna in the second quarter worth approximately $2,269,000. NBT Bank N A NY bought a new stake in Aetna in the second quarter worth approximately $215,000. Finally, Eaton Vance Management grew its stake in Aetna by 18.3% in the second quarter. Eaton Vance Management now owns 1,050,685 shares of the company’s stock valued at $159,526,000 after acquiring an additional 162,502 shares during the period. Institutional investors own 88.41% of the company’s stock.
A number of brokerages have commented on AET. Piper Jaffray Companies reissued a “hold” rating and issued a $187.00 price objective on shares of Aetna in a research note on Friday, November 3rd. Raymond James Financial, Inc. raised Aetna from a “market perform” rating to an “outperform” rating and set a $200.00 price objective for the company in a research note on Friday, November 3rd. Credit Suisse Group began coverage on Aetna in a research note on Thursday, November 2nd. They issued a “neutral” rating and a $174.00 price objective for the company. Zacks Investment Research cut Aetna from a “buy” rating to a “hold” rating in a research note on Thursday, November 2nd. Finally, Citigroup Inc. lifted their target price on Aetna from $183.00 to $197.00 and gave the company a “buy” rating in a research report on Thursday, November 2nd. Eleven investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $172.36.
Shares of Aetna Inc. (NYSE:AET) traded down $0.21 on Thursday, hitting $176.24. The company’s stock had a trading volume of 1,327,400 shares, compared to its average volume of 2,429,967. The company has a market capitalization of $57,540.34, a price-to-earnings ratio of 17.28, a PEG ratio of 1.61 and a beta of 0.61. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.53 and a current ratio of 0.53. Aetna Inc. has a 52-week low of $116.04 and a 52-week high of $184.98.
Aetna (NYSE:AET) last issued its earnings results on Tuesday, October 31st. The company reported $2.45 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.06 by $0.39. The firm had revenue of $14.99 billion for the quarter, compared to analyst estimates of $15.12 billion. Aetna had a return on equity of 21.84% and a net margin of 2.93%. The business’s revenue was down 5.0% on a year-over-year basis. During the same period in the previous year, the company posted $2.07 earnings per share. equities analysts forecast that Aetna Inc. will post 9.78 EPS for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, October 27th. Investors of record on Thursday, October 12th were paid a dividend of $0.50 per share. The ex-dividend date of this dividend was Wednesday, October 11th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.13%. Aetna’s payout ratio is 37.04%.
In related news, EVP Margaret M. Mccarthy sold 10,288 shares of the business’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the sale, the executive vice president now directly owns 33,563 shares in the company, valued at approximately $5,465,734.55. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, President Karen S. Lynch sold 15,271 shares of the business’s stock in a transaction on Monday, September 18th. The shares were sold at an average price of $161.91, for a total value of $2,472,527.61. Following the sale, the president now owns 64,261 shares in the company, valued at $10,404,498.51. The disclosure for this sale can be found here. Insiders own 0.90% of the company’s stock.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.